Suppr超能文献

成骨不全症 Brtl 小鼠致死和非致死表型皮肤对细胞内应激的差异反应:一种蛋白质组学方法。

Differential response to intracellular stress in the skin from osteogenesis imperfecta Brtl mice with lethal and non lethal phenotype: a proteomic approach.

机构信息

Functional Proteomics Lab., Department of Biotechnology, Section of Biochemistry and Molecular Biology, University of Siena, Siena, Italy.

出版信息

J Proteomics. 2012 Aug 3;75(15):4717-33. doi: 10.1016/j.jprot.2012.01.038. Epub 2012 Feb 18.

Abstract

Phenotypic variability in the presence of an identical molecular defect is a recurrent feature in heritable disorders and it was also reported in osteogenesis imperfecta (OI). OI is a prototype for skeletal dysplasias mainly caused by mutations in the two genes coding for type I collagen. No definitive cure is available for this disorder, but the understanding of molecular basis in OI phenotypic modulation will have a pivotal role in identifying possible targets to develop novel drug therapy. We used a functional proteomic approach to address the study of phenotypic variability using the skin of the OI murine model Brtl. Brtl mice reproduce the molecular defect, dominant transmission and phenotypic variability of human OI patients. In the presence of a Gly349Cys substitution in α1(I)-collagen Brtl mice can have a lethal or a moderately severe outcome. Differential expression of chaperones, proteasomal subunits, metabolic enzymes, and proteins related to cellular fate demonstrated that a different ability to adapt to cellular stress distinguished mutant from wild-type mice and mutant lethal from surviving mutant animals. Interestingly, class discovery analysis identified clusters of differentially expressed proteins associated with a specific outcome, and functional analysis contributed to a deeper investigation into biochemical and cellular pathways affected by the disease. This article is part of a Special Issue entitled: Translational Proteomics.

摘要

存在相同分子缺陷时的表型变异性是遗传性疾病的一个反复出现的特征,在成骨不全症 (OI) 中也有报道。OI 是骨骼发育不良的典型代表,主要由编码 I 型胶原的两种基因的突变引起。目前尚无针对这种疾病的明确治疗方法,但对 OI 表型调节的分子基础的理解将在确定可能的靶点以开发新的药物治疗方面发挥关键作用。我们使用功能蛋白质组学方法来研究 OI 鼠模型 Brtl 的表型变异性。Brtl 小鼠复制了人类 OI 患者的分子缺陷、显性遗传和表型变异性。在 α1(I)-胶原中存在 Gly349Cys 取代时,Brtl 小鼠可能会出现致命或中度严重的结果。伴侣蛋白、蛋白酶体亚基、代谢酶和与细胞命运相关的蛋白质的差异表达表明,突变体与野生型小鼠以及突变致死体与存活的突变体动物之间的细胞应激适应能力不同。有趣的是,类别发现分析确定了与特定结果相关的差异表达蛋白簇,功能分析有助于更深入地研究受疾病影响的生化和细胞途径。本文是题为“转化蛋白质组学”的特刊的一部分。

相似文献

4
Cytoskeleton and nuclear lamina affection in recessive osteogenesis imperfecta: A functional proteomics perspective.
J Proteomics. 2017 Sep 7;167:46-59. doi: 10.1016/j.jprot.2017.08.007. Epub 2017 Aug 9.
5
Selective retention and degradation of molecules with a single mutant alpha1(I) chain in the Brtl IV mouse model of OI.
Matrix Biol. 2007 Oct;26(8):604-14. doi: 10.1016/j.matbio.2007.06.005. Epub 2007 Jun 27.
9
A new Col1a1 conditional knock-in mouse model to study osteogenesis imperfecta.
J Bone Miner Res. 2024 Dec 31;40(1):114-124. doi: 10.1093/jbmr/zjae189.

引用本文的文献

2
Murine Animal Models in Osteogenesis Imperfecta: The Quest for Improving the Quality of Life.
Int J Mol Sci. 2022 Dec 22;24(1):184. doi: 10.3390/ijms24010184.
3
Dissecting the phenotypic variability of osteogenesis imperfecta.
Dis Model Mech. 2022 May 1;15(5). doi: 10.1242/dmm.049398. Epub 2022 May 16.
4
7
The Osteocyte Transcriptome Is Extensively Dysregulated in Mouse Models of Osteogenesis Imperfecta.
JBMR Plus. 2019 Feb 11;3(7):e10171. doi: 10.1002/jbm4.10171. eCollection 2019 Jul.
8
Bone biology: insights from osteogenesis imperfecta and related rare fragility syndromes.
FEBS J. 2019 Aug;286(15):3033-3056. doi: 10.1111/febs.14963. Epub 2019 Jul 5.

本文引用的文献

1
Notch regulation of bone development and remodeling and related skeletal disorders.
Calcif Tissue Int. 2012 Feb;90(2):69-75. doi: 10.1007/s00223-011-9541-x. Epub 2011 Oct 16.
2
Hypoxia induces CD133 expression in human lung cancer cells by up-regulation of OCT3/4 and SOX2.
Int J Oncol. 2012 Jan;40(1):71-9. doi: 10.3892/ijo.2011.1207. Epub 2011 Sep 22.
4
Distinct effects of importin α2 and α4 on Oct3/4 localization and expression in mouse embryonic stem cells.
FASEB J. 2011 Nov;25(11):3958-65. doi: 10.1096/fj.10-176941. Epub 2011 Aug 12.
6
New perspectives on osteogenesis imperfecta.
Nat Rev Endocrinol. 2011 Jun 14;7(9):540-57. doi: 10.1038/nrendo.2011.81.
7
Converging pathways in the occurrence of endoplasmic reticulum (ER) stress in Huntington's disease.
Curr Mol Med. 2011 Feb;11(1):1-12. doi: 10.2174/156652411794474419.
8
Chaperoning osteogenesis: new protein-folding disease paradigms.
Trends Cell Biol. 2011 Mar;21(3):168-76. doi: 10.1016/j.tcb.2010.11.007. Epub 2010 Dec 21.
9
New mechanisms and functions of actin nucleation.
Curr Opin Cell Biol. 2011 Feb;23(1):4-13. doi: 10.1016/j.ceb.2010.10.007. Epub 2010 Nov 17.
10
MAPK signalling in cellular metabolism: stress or wellness?
EMBO Rep. 2010 Nov;11(11):834-40. doi: 10.1038/embor.2010.160. Epub 2010 Oct 8.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验